HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postpartum dyspareunia. An unexplored problem.

AbstractOBJECTIVE:
Postpartum dyspareunia has been attributed by authors of obstetric texts to episiotomy tenderness or vaginal atrophy. The nursing literature attributes it to low estrogen levels. This study attempts to examine these assumptions, to clarify the incidence of postpartum dyspareunia and the length of time it is likely to last.
STUDY DESIGN:
Sixty-two women in a private practice were examined between two and eight weeks postpartum and followed prospectively.
RESULTS:
Forty-five percent of parturients developed entry dyspareunia, but only 6% had pain at the sites of vulvar repair. The median length of symptoms in the 39% with nonfocal introital dyspareunia was 5.5 months, and tenderness lasted up to 1 year. Such dyspareunia developed in women having a first (42%) or second (47%) infant, delivering vaginally (42%) or by cesarean section (29%), and lactating (41%) or not lactating (22%). One-third of those affected had severe sexual dysfunction.
CONCLUSION:
Postpartum dyspareunia is quite common and can be a significant source of difficulty in the months after delivery. It is an underdetected problem and deserves more study.
AuthorsM F Goetsch
JournalThe Journal of reproductive medicine (J Reprod Med) Vol. 44 Issue 11 Pg. 963-8 (Nov 1999) ISSN: 0024-7758 [Print] United States
PMID10589408 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Dyspareunia (epidemiology, etiology, pathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Postpartum Period
  • Pregnancy
  • Prospective Studies
  • Vulvar Diseases (complications, etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: